BN Business News
Add your company to Business Communicator →

Business · 03/11/20261 min read

Sobi to present new gout data at ACR Convergence 2026

Summary

STOCKHOLM, Nov. 3, 2026 — Sobi® (STO: SOBI) today announced that six abstracts covering pozdeutinurad (AR882), nanoencapsulated sirolimus plus pegadricase (NASP) and uncontrolled gout will be presented…

Original source language: PR Newswire UK — News ReleasesOpen original release →

Explore insights

Business insights →